|1.||Brown, A T: 4 articles (10/2015 - 10/2013)|
|2.||Skinner, R D: 4 articles (10/2015 - 10/2013)|
|3.||Culp, W C: 4 articles (10/2015 - 10/2013)|
|4.||Arthur, M C: 3 articles (10/2015 - 01/2014)|
|5.||Roberson, P K: 2 articles (10/2015 - 01/2014)|
|6.||Lowery, J D: 2 articles (10/2015 - 10/2013)|
|7.||Nix, J S: 2 articles (02/2015 - 01/2014)|
|8.||Johnson, Jennifer L H: 2 articles (02/2015 - 01/2012)|
|9.||Unger, Evan C: 2 articles (02/2015 - 01/2012)|
|10.||Borrelli, M J: 2 articles (02/2015 - 10/2013)|
10/01/2015 - "Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke Model."
01/01/2014 - "Dodecafluoropentane emulsion (DDFPe), given IV one hour after stroke, has been shown to greatly reduce the percent stroke volume (%SV) in rabbits. "
01/01/2014 - "Dodecafluoropentane Emulsion (DDFPe) Decreases Stroke Size and Improves Neurological Scores in a Permanent Occlusion Rat Stroke Model."
10/01/2013 - "Progress in dodecafluoropentane emulsion as a neuroprotective agent in a rabbit stroke model."
01/01/2012 - "Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model."
12/15/2011 - "For theranostics of solid tumors by means of ultrasound, we designed a nano-sized emulsion containing perfluoropentane (PFC5). "
07/01/2002 - "Radiosensitization of hypoxic tumor cells by dodecafluoropentane: a gas-phase perfluorochemical emulsion."
02/01/2015 - "Radiosensitization of Hs-766T Pancreatic Tumor Xenografts in Mice Dosed with Dodecafluoropentane Nano-Emulsion-Preliminary Findings."
08/01/2014 - "The nanoshells were filled with perfluoropentane and injected directly into excised human breast tumor, and intravenously (IV) into healthy rabbits and Py8119 tumor-bearing athymic nude mice. "
07/01/2002 - "We investigated the ability of dodecafluoropentane (DDFP) to sensitize the moderately radiation-resistant Morris 7777 hepatoma based on our previous inability to modify the radiation response of this tumor. "
|5.||Myocardial Ischemia (Ischemic Heart Diseases)
11/01/1995 - "This study assessed the accuracy of 2% dodecafluoropentane (EchoGen), an intravenous echocardiographic contrast agent, in identifying myocardial area at risk and infarct size in the canine model of myocardial ischemia. "
11/01/1995 - "Protocol 1 assessed the accuracy of myocardial contrast echocardiography using intravenous dodecafluoropentane in defining myocardial area at risk and infarct size in the canine model of regional myocardial ischemia versus gross pathologic specimens stained with monastral blue to determine area at risk and triphenyltetrazolium chloride to determine the area of necrosis. "
|2.||Adenosine Triphosphate (ATP)
|7.||Silicon Dioxide (Sand)
|2.||Heterologous Transplantation (Xenotransplantation)